Рет қаралды 641
Addimmune will be dedicated to revolutionizing treatments for human immunodeficiency virus (HIV), a disease which currently impacts 5 million individuals across the US and Europe. Addimmune's lead treatment, AGT103-T, is a genetically modified autologous cell product candidate that has the potential to be the first functional cure and a potential best-in-class adjuvant treatment for HIV.
Please visit them at www.addimmune.com/
-
If you are interested in presenting, sponsoring, or getting involved in the CONNECTpreneur community, please email us at bicp@opus8.com.
The CONNECTpreneur Investor community is one of the world's largest such groups with over 2500 accredited high-net-worth private investors, angels, family offices, investment groups, and small institutions. If you'd like to have us organize a private investor meeting with our investors, please email us at privateinvestor@opus8.com.
- Your comments are super important to us, so please take a second and say ‘Hi’ in the comments and let us know what you thought of the video … p.s. It would mean the world to us if you hit the subscribe button ;)
- Join us on Social:
Facebook Group:
/ conne
Facebook Page:
/ connectpreneur
Twitter:
/ connectpreneur
LinkedIn Group Page:
/ 8204767
LinkedIn Company Page:
/ 1103
Instagram:
/ connectpren
Website: connectpreneur.org
#CEO #CONNECTpreneur #Opus8 #ECVC #Tech #Technology #Innovation #PhoenixFund #DCTech #Investor #VC #VentureCapital #AngelInvesting #entrepreneurship #entrepreneur #entrepreneurs #Startup #Startups #technology